MedPath

ITALFARMACO SA

🇪🇸Spain
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.italfarmaco.es

Clinical Trials

2

Active:1
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 3
1 (50.0%)

Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

Phase 3
Completed
Conditions
Vaginal Atrophy
Interventions
Other: Placebo
First Posted Date
2020-10-05
Last Posted Date
2020-12-11
Lead Sponsor
Italfarmaco S.A
Target Recruit Count
167
Registration Number
NCT04574999
Locations
🇪🇸

Hospital Sierrallana, Torrelavega, Cantabria, Spain

🇪🇸

Hospital Ruber Internacional, Madrid, Castiglia, Spain

🇪🇸

Centre Mèdic Teknon S.L., Barcelona, Catalogna, Spain

and more 9 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath